Announcements Trials
Browse Landscape

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 42Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1Cardiovascular Diseases 1

Interventions

Surveys and Questionnaires 38Blood Specimen Collection 24Specimen Handling 14Radiotherapy 12Surgical Procedures, Operative 10Interviews as Topic 10Observation 9Magnetic Resonance Spectroscopy 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mastectomy, Segmental 5Biopsy 5ribociclib 4palbociclib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Mental Status and Dementia Tests 4Magnetic Resonance Imaging 4Ipilimumab 4Immune Checkpoint Inhibitors 4High-Throughput Nucleotide Sequencing 4Echocardiography 4Bevacizumab 4lorlatinib 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Observational × acalabrutinib × Clear all
NCT06205498 2026-04-23

ARISE

AstraZeneca

Active not recruiting
151 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06561243 2024-08-21

Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies

University Hospital, Caen

Active not recruiting
15,000 enrolled

Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡